Genome Web Breaking News
- Bio-Rad Laboratories, Diagenode Partner to Offer Droplet Digital PCR ATAC-Seq Services
- Personalis, Merck KGaA to Study Cancer Biomarkers Using Immunogenomics Platform
- Epigenomics Posts 69 Percent Drop in Q3 Revenues
- Schizophrenia Loci Overlap in East Asians, Europeans but Polygenic Risk Scores Don't Transfer Well
- Type I CRISPR Systems Can Be Used to Edit Eukaryotic Cells
Stat
- Trump’s stalling on flavored vape ban draws blowback — and fears of lasting damage to American health
- STAT Plus: Pharmalittle: How Purdue planted its ‘anti-story’; how much does that ‘free’ flu shot cost?
- First CRISPR treatment for blood diseases shows early benefits in two patients
- STAT Plus: Novo Nordisk’s parent company to launch research incubator in Boston
- How Purdue planted its ‘anti-story’ and delayed the reckoning for its role in the opioid epidemic
NYT science news
- In the Race to Live on Land, Lichens Didn’t Beat Plants
- As Climate Risk Grows, Cities Test a Tough Strategy: Saying ‘No’ to Developers
- Science Was Her Lifeline. Now She Helps Other Girls Discover It.
- Will Science Ever Give Us a Better Night’s Sleep?
- California to Stop Buying From Automakers That Backed Trump on Emissions
Xconomy news
- Novo Ventures Commits $25M to Grow Discovery “Greenhouse” in Boston
- Inozyme Pharma Names Pedro Huertas Chief Medical Officer
- Verseau Therapeutics Names Tim Smith Chief Business Officer
- With “Inflection Year” Ahead, Ovid Adds Novartis’s Tardio to C-Suite
- Underdog Launches With $4M to Target “Toxic” Form of Cholesterol
Fierce Biotech
- FDA clears its first duodenoscope with a disposable head to cut infection risks
- Relay Therapeutics beefs up leadership as it looks to the clinic
- Myovant's oral prostate cancer drug matches incumbent in phase 3
- Novartis tight-lipped on MedCo buyout rumors
- Novo Ventures, Broad Institute form drug discovery pact
Fierce Medical Devices
- FDA clears its first duodenoscope with a disposable head to cut infection risks
- FDA approves first contact lens to slow childhood nearsightedness
- Novartis taps growing Biofourmis for digital heart failure project
- AHA: Janssen drops clinical sites for smartphones, wearables in 100% virtual Invokana study
- Fractyl's intestine-resurfacing device shows gains in HbA1c and liver fat, plus 2-year data